XPeng Vs. NIO: Can Tech, Trend Turn The Tables Ahead Of Q3 Earnings? – XPeng (NYSE:XPEV), NIO (NYSE:NIO) November 18, 2024
Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024 – CARISMA Therapeutics (NASDAQ:CARM) November 18, 2024
Spotlight on Applied Optoelectronics: Analyzing the Surge in Options Activity – Applied Optoelectronics (NASDAQ:AAOI) November 17, 2024
Flux Power Provides Update on Inventory Restatement and Timeline to Report Fiscal FY 2024 and Q1 2025 Financial Results – Flux Power Holdings (NASDAQ:FLUX) November 17, 2024
